| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Hartmut Hengel,2 and
Pamela J. Bjorkman1,3*
Division of Biology,1 Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California 91125,3 Institut für Virologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany2
Received 5 July 2007/ Accepted 15 January 2008
Recognition of immunoglobulin G (IgG) by surface receptors for the Fc domain of immunoglobulin G (Fc
), Fc
Rs, can trigger both humoral and cellular immune responses. Two human cytomegalovirus (HCMV)-encoded type I transmembrane receptors with Fc
-binding properties (vFc
Rs), gp34 and gp68, have been identified on the surface of HCMV-infected cells and are assumed to confer protection against IgG-mediated immunity. Here we show that Fc
recognition by both vFc
Rs occurs independently of N-linked glycosylation of Fc
, in contrast with the properties of host Fc
Rs. To gain further insight into the interaction with Fc
, truncation mutants of the vFc
R gp68 ectodomain were probed for Fc
binding, resulting in localization of the Fc
binding site on gp68 to residues 71 to 289, a region including an immunoglobulin-like domain. Gel filtration and biosensor binding experiments revealed that, unlike host Fc
Rs but similar to the herpes simplex virus type 1 (HSV-1) Fc receptor gE-gI, gp68 binds to the CH2-CH3 interdomain interface of the Fc
dimer with a nanomolar affinity and a 2:1 stoichiometry. Unlike gE-gI, which binds Fc
at the slightly basic pH of the extracellular milieu but not at the acidic pH of endosomes, the gp68/Fc
complex is stable at pH values from 5.6 to pH 8.1. These data indicate that the mechanistic details of Fc binding by HCMV gp68 differ from those of host Fc
Rs and from that of HSV-1 gE-gI, suggesting distinct functional and recognition properties.
Published ahead of print on 23 January 2008.
Present address: Department of Microbiology and Immunology, Stanford University, Palo Alto, CA 94305.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|